 |
|
Colorectal Cancer Test Use Among Persons Aged  50 Years—United States, 2001
JAMA. 2003;289:2492-2493.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
MMWR. 2003;52:193-196
1 table, 2 figures omitted
Colorectal cancer is the second leading cause of cancer-related death in the United States.1 The lifetime risk for having colorectal cancer diagnosed is 6%.2 Screening measures decrease the incidence and mortality of colorectal cancer by detecting early disease and removing precancerous lesions.3 The U.S. Preventive Services Task Force recommends routine cancer screening for U.S. adults aged  50 years with one or a combination of the following screening options: annual home fecal occult blood testing (FOBT), sigmoidoscopy every 5 years, colonoscopy every 10 years, or double contrast barium enema every 5 years.3 To estimate rates and evaluate trends for colorectal cancer test use among U.S. adults aged 50 years, CDC analyzed data from the 2001 Behavioral Risk Factor Surveillance System (BRFSS) on the use of FOBT and sigmoidoscopy/colonoscopy and compared the data for 2001 with those for 1997 and 1999. This report summarizes the . . . [Full Text of this Article]
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
A sensitive method to quantify human long DNA in stool: relevance to colorectal cancer screening.
Zou et al.
Cancer Epidemiol. Biomarkers Prev. 2006;15:1115-1119.
ABSTRACT
| FULL TEXT
Family History Assessment to Detect Increased Risk for Colorectal Cancer: Conceptual Considerations and a Preliminary Economic Analysis
Ramsey et al.
Cancer Epidemiol. Biomarkers Prev. 2005;14:2494-2500.
ABSTRACT
| FULL TEXT
|
